Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy. Issue 3 (8th March 2021)

• Record Type: Journal Article
• Authors: Højgaard, Pil; Witting, Nanna; Rossing, Kasper; Pecini, Redi; Hartvig Lindkær Jensen, Thomas; Hasbak, Philip; Diederichsen, Louise P
• Is Part Of: Oxford medical case reports. Volume 2021:Issue 3(2021)
• Publication Date: 2021-03-08
• Subjects: Clinical medicine -- Case studies -- Periodicals; 616.09
• DOI: 10.1093/omcr/omaa150
• Languages: English
• ISSNs: 2053-8855

Abstract

Abstract: Insight into predictors of cardiac involvement in inflammatory myopathies is sparse. A negative prognostic role of anti-mitochondrial antibodies (AMA) has been noticed and is supported by the current case. We describe a male patient who at the age 40 suffered a cardiac arrest and over the following months experienced progressive heart failure, arrhythmias and proximal muscle weakness. Clinical, genetic and serologic testing and repeated imaging- and histopathological investigations resulted in a diagnosis of AMA-associated, necrotizing, inflammatory myositis with cardiac involvement. Besides a cardiac resynchronization therapy defibrillator, heart failure and antiarrhythmic drugs the patient received successive immunosuppressants, which improved skeletal muscle strength but not cardiac disease progression. At age 45 he died from end-stage heart failure. Clinicians must be aware of AMA-associated myositis as a cause of unclarified heart disease, even in patients with initially sparse extra-cardiac manifestations. Further knowledge of treatment strategies is highly needed for this disease entity.